Evidence Backs Low-dose Aspirin for Ages 50-59, Say USPSTF, AAFP

On April 12, the U.S. Preventive Services Task Force issued its final recommendation statement on the use of aspirin for primary prevention of cardiovascular disease and colorectal cancer.